- Home
- About the University
- Find staff
- Anders Eilard
Anders Eilard
Doctoral Student
Department of Infectious Diseases-
Immune Control, HBsAg Loss or Flare Requiring Liver Transplant-Diverse Outcomes After Stopping NUC
Therapy
Katarina Lund, Miriam Frankal, Anders Eilard, Joakim Bedner Stenbäck, Erik Alestig, Arno Furquim d'Almeida, Staffan Nilsson, Thomas Vanwolleghem, Johan Westin, Johan Ringlander, Gustaf Rydell, Magnus Lindh
VIRUSES-BASEL - 2026 -
Viral particles do not contribute significantly to serum levels of hepatitis B surface antigen which is produced mainly from integrated HBV DNA in most patients with chronic hepatitis
B
Anders Eilard, Gustaf Rydell, Joakim Bedner Stenbäck, Johan Ringlander, Magnus Lindh
INFECTIOUS DISEASES - 2026 -
Long-Term Outcome of Chronic Hepatitis B-Histological Score and Viral Genotype Are Important Predictors of Hepatocellular
Carcinoma
Anders Eilard, Johan Ringlander, Maria E Andersson, Staffan Nilsson, Gunnar Norkrans, Magnus Lindh
JOURNAL OF VIRAL HEPATITIS - 2025 -
Outcomes of chronic and vertically acquired occult hepatitis
B
Anders Eilard
2024 -
Occult hepatitis B infection in children born to HBeAg-positive women confers a low long-term risk for HBsAg-positive
infection
Anders Eilard, Maria E Andersson, Rune Wejstal, Gunnar Norkrans, Magnus Lindh
INFECTION - 2024 -
Hepatitis B virus particles in serum contain minus strand DNA and degraded pregenomic RNA of variable and inverse
lengths
Johan Ringlander, Sebastian Malmström, Anders Eilard, Lucia Gonzales Strömberg, Joakim B. Stenback, Maria E Andersson, Simon B. Larsson, Michael Kann, Staffan Nilsson, Kristoffer Hellstrand, Gustaf E Rydell, Magnus Lindh
LIVER INTERNATIONAL - 2024 -
Management of hepatitis B virus infection, updated Swedish
guidelines.
Johan Westin, Soo Aleman, Maria Castedal, Ann-Sofi Duberg, Anders Eilard, Björn Fischler, Christian Kampmann, Karin Lindahl, Magnus Lindh, Gunnar Norkrans, Stephan Stenmark, Ola Weiland, Rune Wejstål
Infectious diseases - 2020 -
Vertically acquired occult hepatitis B virus infection may become overt after several
years
Anders Eilard, Maria Andersson, Rune Wejstål, Johan Ringlander, Gunnar Norkrans, Magnus Lindh
Journal of Infection - 2019 -
HBsAg quantification for identification of liver disease in chronic hepatitis B virus
carriers
Simon B. Larsson, Anders Eilard, Sebastian Malmström, Charles Hannoun, A. P. Dhillon, Gunnar Norkrans, Magnus Lindh
Liver International - 2014 -
Genotype impact on long-term virological outcome of chronic hepatitis B virus
infection
Sebastian Malmström, Anders Eilard, Simon B. Larsson, Charles Hannoun, Gunnar Norkrans, Magnus Lindh
Journal of Clinical Virology - 2012 -
IL28B polymorphisms determine early viral kinetics and treatment outcome in patients receiving peginterferon/ribavirin for chronic hepatitis C genotype
1
Magnus Lindh, Martin Lagging, B Arnholm, Anders Eilard, Staffan Nilsson, Gunnar Norkrans, Jonas Söderholm, T Wahlberg, Rune Wejstål, Johan Westin, Kristoffer Hellstrand
Journal of Viral Hepatitis - 2011 -
Hepatitis C treatment response kinetics and impact of baseline
predictors.
Magnus Lindh, B Arnholm, Anders Eilard, M Färkkilä, Kristoffer Hellstrand, Martin Lagging, N Langeland, K Mørch, Staffan Nilsson, C Pedersen, M R Buhl, T Wahlberg, Rune Wejstål, Johan Westin, Gunnar Norkrans
Journal of viral hepatitis - 2011 -
Core mutations, IL28B polymorphisms and response to peginterferon/ribavirin treatment in Swedish patients with hepatitis C virus genotype 1
infection
Erik Alestig, B. Arnholm, Anders Eilard, Martin Lagging, Staffan Nilsson, Gunnar Norkrans, T. Wahlberg, Rune Wejstål, Johan Westin, Magnus Lindh
BMC Infectious Diseases - 2011 -
Response prediction and treatment tailoring for chronic hepatitis C virus genotype 1
infection
Magnus Lindh, Erik Alestig, Birgitta Arnholm, Anders Eilard, Kristoffer Hellstrand, Martin Lagging, Thomas Wahlberg, Rune Wejstål, Johan Westin, Gunnar Norkrans
J Clin Microbiol - 2007